Cambridge Investment Research Advisors’s Innovator Equity Defined Protection ETF - 1 Yr January ZJAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$659K Buy
23,555
+969
+4% +$26.9K ﹤0.01% 2705
2026
Q1
$616K Buy
22,586
+3,489
+18% +$95.6K ﹤0.01% 2617
2025
Q4
$522K Sell
19,097
-6,720
-26% -$182K ﹤0.01% 2679
2025
Q3
$694K Buy
25,817
+373
+1% +$9.93K ﹤0.01% 2362
2025
Q2
$670K Buy
25,444
+8,740
+52% +$225K ﹤0.01% 2274
2025
Q1
$426K Buy
+16,704
New +$430K ﹤0.01% 2585

Other funds holding ZJAN

Cambridge Investment Research Advisors's ZJAN Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Innovator Equity Defined Protection ETF - 1 Yr January (ZJAN) stake by 4.3% in Q2 2026, buying an estimated $26.9K and bringing the position to 23,555 shares worth $659K. The position accounts for ﹤0.01% of the portfolio, ranked #2705.

Cambridge Investment Research Advisors first reported a position in ZJAN in Q1 2025 and has held it in 6 quarters since. The position peaked at $694K in Q3 2025. 45 funds tracked by Wall St. Rank hold ZJAN as of Q2 2026.

  • Cambridge Investment Research Advisors held 23,555 shares of Innovator Equity Defined Protection ETF - 1 Yr January worth $659K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 969 Innovator Equity Defined Protection ETF - 1 Yr January shares in Q2 2026, an estimated $26.9K.
  • Innovator Equity Defined Protection ETF - 1 Yr January made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2705 holding.
  • Cambridge Investment Research Advisors first reported a position in Innovator Equity Defined Protection ETF - 1 Yr January in Q1 2025 and has held it in 6 quarters since.
  • Cambridge Investment Research Advisors's Innovator Equity Defined Protection ETF - 1 Yr January position peaked at $694K in Q3 2025.
  • 45 funds tracked by Wall St. Rank held Innovator Equity Defined Protection ETF - 1 Yr January as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.